Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment. [electronic resource]
Producer: 20100406Description: 389-91 p. digitalISSN:- 1129-2377
- Azepines -- pharmacology
- Calcitonin Gene-Related Peptide -- metabolism
- Calcitonin Gene-Related Peptide Receptor Antagonists
- Cerebral Arteries -- drug effects
- Clinical Trials as Topic
- Dipeptides -- pharmacology
- Humans
- Imidazoles -- pharmacology
- Migraine Disorders -- drug therapy
- Piperazines
- Quinazolines -- pharmacology
- Receptors, Calcitonin Gene-Related Peptide -- metabolism
- Serotonin Receptor Agonists -- pharmacology
- Treatment Failure
- Tryptamines -- pharmacology
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.